Approval · Notice of Compliance 10065 · 2009
METVIX: Notice of Compliance 10065
Issued February 26, 2009
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 10065
- Date
- February 26, 2009
- Company
- Galderma Canada Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- Antineoplastic agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| METVIX | 02323273 | Marketed |
Medicinal ingredients
- METHYL AMINOLEVULINATE HYDROCHLORIDE 168 MG per G